Eli Lily 's Latest Scheme
- Thread starter Mr.Tired
- Start date
- Status
Mr. Blonde
GLP-1 Enthusiast
Huh, I guess Eli Lilly can actually get shittier. Thought they hit rock bottom already. Guess that's my fault for underestimating them.
Danger1212 said:Panic buying Peptides reminds me of COVID times when we would panic buy ammunition, primers, powder, and whatever else we could think of.
They were the best of times and they were the worst of times…
I was clearly invited to a different party
. I was panic buying toilet paper, masks, and hand sanitizer.
Physician Use Only, meaning they will go to a doctor-patient model typically using telemedicine, or by submitting a form or prescription. It's a way to lock them down and enable providers to charge through the ass for them.Ragnar said:
Lovedog100
GLP-1 Apprentice
RFK is a buffoon that should seriously consider retiring. Then he could do something that he is qualified for. Sitting in front of the TV while scrolling his phone.NBA_MiddleAgedGirl said:
Danger1212
GLP-1 Apprentice
Fair enoughGrogu said:I was clearly invited to a different party
We all stocked up on what we thought would keep us alive. 
I hope the day never comes that I tell the guns & ammo forum, “this reminds me of the time I panic bought all those peptides…” ….Wait, what…?
lessthanhalf
GLP-1 Specialist
In an ideal world , we want the drug companies to keep making plenty of money from GLP drugs to make it worthwhile to keep developing new ones, as that process is extremely expensive. And to have grey ones be readily available. They are unlikely to sell legit GLP's at reasonable prices for some time, except perhaps sema once it is off patent.
I would love to know how many people are actually using compounded or grey GLP peptides compared to the legit versions, and whether it is more or less. Given the number of newspaper articles out there recently there sounds like a lot of people using grey GLP's. But the drug companies are still making plenty of money. While there are going to be some people using grey GLP's who could afford the legit ones, there are a lot and most likely a large majority who could not afford their current prices, so grey peptide use is not necessarily cutting into their market as much as they might think.
I saw an article yesterday where lily refused an australian deal to have tirzepatide be available as a subsidised medicine for diabetics, something they have applied for 4 times, but obviously the price offered by the government was not high enough. So not going to be available for obesity in the near future here at subsidised prices. Ozempic already is , but only if you are diabetic or obese and have already had a heart attack or stroke. Which is a bit late really.
Even in the US there is political pressure on the companies to reduce prices, and some deals have been made, given recent news about providing them for $50 to older patients.
But overall real price reductions are not going to happen until there is more competition, especially from the chinese companies who I think are more likely to sacrifice profit margins for market share, once their GLP's are more available.
Grey availability is really up to china, I do not think they care much about about low grade political pressure from the US , but they could be convinced to crack down on it as part of some larger trade deal. Otherwise my guess is it won't happen until it interferes with local legit drug companies, there is one new chinese GLP now available and it forced drastic drops in prices of tirz and sema in china, but once some of the others in development make it I suspect the grey market might get hit. And the chinese government could definitely stop grey peptides from being made if they wanted to. I am not sure it could survive as a totally underground black market in china given it requires fairly technical production equipment to make GLP peptides. And china's generally harsh enforcement style. I cannot see customs enforcement in the west substantially stopping chinese peptides given the vast volumes of packages being imported from china to everywhere else, there are just too many to inspect.
I would love to know how many people are actually using compounded or grey GLP peptides compared to the legit versions, and whether it is more or less. Given the number of newspaper articles out there recently there sounds like a lot of people using grey GLP's. But the drug companies are still making plenty of money. While there are going to be some people using grey GLP's who could afford the legit ones, there are a lot and most likely a large majority who could not afford their current prices, so grey peptide use is not necessarily cutting into their market as much as they might think.
I saw an article yesterday where lily refused an australian deal to have tirzepatide be available as a subsidised medicine for diabetics, something they have applied for 4 times, but obviously the price offered by the government was not high enough. So not going to be available for obesity in the near future here at subsidised prices. Ozempic already is , but only if you are diabetic or obese and have already had a heart attack or stroke. Which is a bit late really.
Even in the US there is political pressure on the companies to reduce prices, and some deals have been made, given recent news about providing them for $50 to older patients.
But overall real price reductions are not going to happen until there is more competition, especially from the chinese companies who I think are more likely to sacrifice profit margins for market share, once their GLP's are more available.
Grey availability is really up to china, I do not think they care much about about low grade political pressure from the US , but they could be convinced to crack down on it as part of some larger trade deal. Otherwise my guess is it won't happen until it interferes with local legit drug companies, there is one new chinese GLP now available and it forced drastic drops in prices of tirz and sema in china, but once some of the others in development make it I suspect the grey market might get hit. And the chinese government could definitely stop grey peptides from being made if they wanted to. I am not sure it could survive as a totally underground black market in china given it requires fairly technical production equipment to make GLP peptides. And china's generally harsh enforcement style. I cannot see customs enforcement in the west substantially stopping chinese peptides given the vast volumes of packages being imported from china to everywhere else, there are just too many to inspect.
Lovedog100
GLP-1 Apprentice
I know for us that it looks like the grey market is huge. In truth, most people are uncomfortable with non FDA approved drugs. They are even more uncomfortable with buying from Chinese suppliers. I know for myself, I looked for a month before I found a supplier that didn't look overly shady.lessthanhalf said:
Once Reta started working for me, I tried to get my son, and a long time friend of mine to give it a try. Neither of them would try an unapproved drug, nor would they try anything from China. My friend has been getting bigger and bigger for as long as I've known him. He has got to be well over 400 lbs. I offered to give him a couple of vials and show him how to reconstitute and use the Reta. He told me that he would do his own research and get back to me. I haven't heard a word from him since.
That said, I bought stock in Lilly after I saw how well Ozempic was selling, knowing that Lilly would have the next latest and greatest. I bought more Lilly stock than I was comfortable with buying. I wish all of my investments would do as well as Lilly has.
randompersonrandom
GLP-1 Specialist
oh, are we memory-laning COVID hoarding? it just so happened that we ALREADY had 30 rolls of tp in both bathrooms because it's an easy thing to get the free delivery on at Walmart if you just want one or two things, and both bathrooms already had a bidet. but we DID panic-hoard fifty pounds of organic white flour and thirty pounds of sugar. I think we just wanted to feel like we were participating, honestly.
Lily is really going all out. What with this case and removing the golden dose from the new Mounjaro pens. They are trying to make sure they can squeeze every last penny out of their consumers. I really hope this case fails. I'm grateful they spent time and money on the R&D for these compounds, but they are trying to punish people who probably wouldn't even use their products in the first place if it weren't for the current alternative avenues.
Month
Recently Joined 🚫No Source Discussion🚫
This won't affect internationally sourced glp-1's will it? Wouldn't this law only affect domestic American pharmacies and at most America might enforce stronger and more frequent customs seizures, but they have no say on how GLP-1's are globally classified? Could FDA's decision influence other national regulators? such as EU EMA?
BNLFL
GLP-1 Specialist
If you ordered that, I'll be more like 8-11 weeks they're saying.Danger1212 said:
- Status
